In addition to the INSS, NB patients can be stratified into low, intermediate, and high-risk disease groups depending on the age at diagnosis, stage, histology, MYCN status, and tumor cell ploidy (reviewed in [16]). The gene discussed is MYCN; the disease is neuroblastoma.